Tenet Healthcare (THC) Tops Q4 EPS by 23c, Revenues Beat; Offers FY19 EPS Guidance Above Consensus, FY19 Revenue Mid-Point Views Abvoe Consensus, Provides Q1 EPS/Revenue Outlook

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. CBRS
2. FDX
3. KBH
4. HON
5. HTZ
6. MRK
7. TTWO
8. USO
9. QCOM
10. INFY

Go back to Tenet Healthcare (THC) Tops Q4 EPS by 23c, Revenues Beat; Offers FY19 EPS Guidance Above Consensus, FY19 Revenue Mid-Point Views Abvoe Consensus, Provides Q1 EPS/Revenue Outlook

Tenet Reports Results for the Fourth Quarter and Year Ended December 31, 2018 and Issues Outlook for 2019

February 25, 2019 4:15 PM EST

Tenet reported net income from continuing operations attributable to Tenet common shareholders of $108 million or $1.04 per diluted share in 2018. In the fourth quarter of 2018, Tenet reported a net loss from continuing operations attributable to Tenet common shareholders of $5 million or $0.05 per diluted share. Adjusted diluted earnings per share from continuing operations was $1.86 in 2018, above the Companys Outlook range of $1.44 to $1.83 and an increase of 130 percent over 2017. In the fourth quarter, Adjusted diluted earnings per share from continuing operations was $0.51. Adjusted EBITDA was $2.560 billion in 2018, above the midpoint... More